ElleS review

ElleS offers a concrete microdose product rather than only describing dose customization. The main qualification is formulation: its priced microdose products are dissolving tablets, while the lower-versus-standard comparison on the site spans different routes. Someone who wants an injection cannot assume the tablet price applies. Confirm the prescribed amount, formulation, commitment and pharmacy before deciding whether this is the particular low-dose service you want.

Vs median

$4/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Prices the low dose on its own

Consult

Confirm any separate fee

Dietitian

Not confirmed

Labs

Not stated

Pricing

Check plan terms

ElleS names its pharmacy: Belmar; Strive; Epiq. Laboratory requirements are not publicly stated; confirm them with the clinician. Confirm whether clinician visits cost extra.

ElleS offers named microdose semaglutide and tirzepatide orally disintegrating tablets alongside standard injectable and oral-capsule products. The microdose tablets have their own starting monthly figures. Comparing those directly with the injection price would mix formulations, so the lower headline does not establish a same-product microdose discount. The website also lists microdose injections with limited availability but does not print a price for them. Belmar, Strive and Epiq are named as pharmacy partners. Services depend on state and prescribing eligibility. The public microdose prices do not identify the daily milligram amount, required commitment or final pharmacy formulation, all of which should be settled before purchase. The public treatment information does not establish a mandatory laboratory schedule; confirm testing requirements with the clinician.

The dose and commitment attached to the starting price are not published

• Microdose injection availability is limited and no price is shown
• A tablet-to-injection comparison does not prove a microdose discount

ElleS is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the microdosing evidence shows
• Comparing the complete treatment cost
• Compare treatment costs